Your browser doesn't support javascript.
loading
The eight-year long-term follow-up on the effectiveness of the quadrivalent human papillomavirus vaccine in Chinese women 20-45 years of age.
Zhao, Chao; Zhao, Yun; Li, Jingran; Li, Mingzhu; Su, Yanyan; Mi, Xin; La Tu, Su Yi; Shen, Danhua; Ren, Lihua; Li, Yanyan; Wang, Linhong; Wei, Lihui.
Afiliação
  • Zhao C; Department of Obstetrics and Gynecology, Peking University People's Hospital, Beijing, China.
  • Zhao Y; Department of Obstetrics and Gynecology, Peking University People's Hospital, Beijing, China.
  • Li J; Department of Obstetrics and Gynecology, Peking University People's Hospital, Beijing, China.
  • Li M; Department of Obstetrics and Gynecology, Peking University People's Hospital, Beijing, China.
  • Su Y; Department of Obstetrics and Gynecology, Shunyi Maternity and Child Health Hospital, Beijing, China.
  • Mi X; Department of Obstetrics and Gynecology, Shunyi Maternity and Child Health Hospital, Beijing, China.
  • La Tu SY; Department of Obstetrics and Gynecology, Xilinguolemeng Xianghuangqi Maternity and Child Health Hospital, Inner Mongolia Autonomous Region, China.
  • Shen D; Department of Obstetrics and Gynecology, Peking University People's Hospital, Beijing, China.
  • Ren L; Department of Obstetrics and Gynecology, Peking University People's Hospital, Beijing, China.
  • Li Y; Department of Obstetrics and Gynecology, Peking University People's Hospital, Beijing, China.
  • Wang L; National Center for Women and Children's Health, Chinese Center for Disease Control and Prevention, Beijing, China.
  • Wei L; Department of Obstetrics and Gynecology, Peking University People's Hospital, Beijing, China.
Hum Vaccin Immunother ; 18(5): 2052700, 2022 11 30.
Article em En | MEDLINE | ID: mdl-35358015
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Displasia do Colo do Útero / Infecções por Papillomavirus / Vacina Quadrivalente Recombinante contra HPV tipos 6, 11, 16, 18 Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies Limite: Adult / Female / Humans / Middle aged País/Região como assunto: Asia Idioma: En Revista: Hum Vaccin Immunother Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China País de publicação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Displasia do Colo do Útero / Infecções por Papillomavirus / Vacina Quadrivalente Recombinante contra HPV tipos 6, 11, 16, 18 Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies Limite: Adult / Female / Humans / Middle aged País/Região como assunto: Asia Idioma: En Revista: Hum Vaccin Immunother Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China País de publicação: Estados Unidos